RHDV2 is considered a foreign animal disease, meaning it is not naturally occurring in the United States (U.S.), and, therefore, a mandatory reportable disease closely monitored by state and federal agencies.
Rabbits may die without showing any symptoms at all.
Our goal for the future is a readily available safe and humane RHDV2 vaccine for veterinary administration that does not require special permits or suffer delays in importation. (PDF/185.1 KB) Vaccines work by preparing the immune system (the body’s natural defences) to defend itself against a specific disease.
Don’t panic. (PDF/398.67 KB) If vaccines are sold to all states, there would be a critical shortage for RHDV2-positive states.
(PDF/338.21 KB) (PDF/175.56 KB) BC vets who would like to join in vaccine orders, please Biosecurity measures are essential to protect your rabbit in an outbreak, even if they are vaccinated.
When the rabbit comes into contact with these or similar viruses, these antibodies, together with other components of the immune system, will be able to kill the viruses and help protect against the diseases.Four laboratory studies were conducted in young rabbits that showed protection began three weeks after vaccination and lasted 12 months against RHDV1 and RHDV2.
(PDF/191.08 KB) Is it RHDV2.
(PDF/71.09 KB) Here is a link to a paper looking at the protective nature of Filavac vaccine against a wild-type strain of RHDV2 in France (the same genotype as the virus identified in WA). (PDF/343.69 KB)
(PDF/393.13 KB)
Nobivac Myxo-RHD Plus is a vaccine used in rabbits to reduce death and clinical signs due to myxomatosis and rabbit haemorrhagic disease (RHD).
(PDF/327.21 KB)
A non-profit rabbit rescue and education organizationRabbit Hemorrhagic Disease Virus (RHDV) is a highly contagious disease caused by a calicivirus that affects rabbits. (PDF/315.45 KB) Website mission.
Nobivac Myxo-RHD Plus is a vaccine used in rabbits to reduce death and clinical signs due to myxomatosis and rabbit haemorrhagic disease (RHD). We strongly recommend vaccinating all rabbits. (PDF/182.64 KB)
(PDF/421.82 KB)
We must respond quickly if an outbreak occurs. Protection starts at three weeks and lasts for one year. (PDF/229.58 KB) (PDF/84.66 KB)
The two vaccines currently available for import to the US in 2020, Eravac (RHDV2) and Filavac (RHDV1 and RHDV2), are produced by infecting rabbits with RHDV in a laboratory and killing them to make liver-derived vaccines.
(PDF/85.48 KB) (PDF/147.01 KB) (PDF/74.3 KB)
The two killed/inactivated vaccines currently available for import (Eravac and Filavac) are produced by infecting rabbits and then euthanizing them after a period of time to collect the virus from their livers and spleens.
(PDF/69.01 KB) (PDF/146.78 KB)
RHDV2 is considered a foreign animal disease, meaning it is not naturally occurring in the United States (U.S.), and, therefore, a mandatory reportable disease closely monitored by state and …
Log In. myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant) The vaccine strain is a myxoma virus expressing the capsid protein gene of rabbit haemorrhagic disease virus and it offers the duration of immunity of 1 year against both RHDV and myxoma virus. There are many strains of the RHD virus, however it is the rare Type 2 (RHDV2) strain affecting rabbits in the U.S. RHDV2 is a fatal, viral disease that affects both domestic and (PDF/183.62 KB)
RHD spreads via rabbit to rabbit contact (often wild rabbits), in the air and also via insect bites. It has been proven safe and effective in protecting rabbits from this disease.
(PDF/67.84 KB) (PDF/116.35 KB) (PDF/465.5 KB)
What is Rabbit Hemorrhagic Disease? (PDF/184.46 KB)
RHDV2 is considered a foreign animal disease, meaning it is not naturally occurring in the United States (U.S.), and, therefore, a mandatory reportable disease closely monitored by state and federal agencies.
(PDF/89.01 KB)
(PDF/151.39 KB) (PDF/507.14 KB) (PDF/94.46 KB)
(PDF/180.21 KB) (PDF/107.42 KB)
(PDF/420.09 KB)
Science.
(PDF/179.34 KB) It is important that HRS members cooperate and follow federal, state, and local governmental agency directions with regard to epidemic issues, such as RHDV. (PDF/68.92 KB)
(PDF/315.46 KB)
(PDF/149.19 KB) (PDF/150.67 KB)
(PDF/148.02 KB)
(PDF/101.31 KB) (PDF/101.31 KB)
(PDF/367.98 KB) (PDF/74.3 KB)
(PDF/71.09 KB)